Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
<p>Effects of treatment with duvelisib and ibrutinib on the numbers of T cells in in mice receiving samples from the same patients in Figure 6.</p>
שמור ב:
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | , , , , , , , , , , , , , , |
| יצא לאור: |
2025
|
| נושאים: | |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
| _version_ | 1849927633321590784 |
|---|---|
| author | Shih-Shih Chen (15314296) |
| author2 | Jacqueline C. Barrientos (15314299) Gerardo Ferrer (15314302) Morgan King-Richards (15314305) Yu-Ju Chen (15314308) Priyadarshini Ravichandran (15314311) Michael Ibrahim (15314314) Yasmine Kieso (15314317) Sheila Waters (15314320) Jeffery L. Kutok (15314323) Marisa Peluso (15314326) Sujata Sharma (15314329) David T. Weaver (15314332) Jonathan A. Pachter (15027774) Kanti R. Rai (15314335) Nicholas Chiorazzi (15314338) |
| author2_role | author author author author author author author author author author author author author author author |
| author_facet | Shih-Shih Chen (15314296) Jacqueline C. Barrientos (15314299) Gerardo Ferrer (15314302) Morgan King-Richards (15314305) Yu-Ju Chen (15314308) Priyadarshini Ravichandran (15314311) Michael Ibrahim (15314314) Yasmine Kieso (15314317) Sheila Waters (15314320) Jeffery L. Kutok (15314323) Marisa Peluso (15314326) Sujata Sharma (15314329) David T. Weaver (15314332) Jonathan A. Pachter (15027774) Kanti R. Rai (15314335) Nicholas Chiorazzi (15314338) |
| author_role | author |
| dc.creator.none.fl_str_mv | Shih-Shih Chen (15314296) Jacqueline C. Barrientos (15314299) Gerardo Ferrer (15314302) Morgan King-Richards (15314305) Yu-Ju Chen (15314308) Priyadarshini Ravichandran (15314311) Michael Ibrahim (15314314) Yasmine Kieso (15314317) Sheila Waters (15314320) Jeffery L. Kutok (15314323) Marisa Peluso (15314326) Sujata Sharma (15314329) David T. Weaver (15314332) Jonathan A. Pachter (15027774) Kanti R. Rai (15314335) Nicholas Chiorazzi (15314338) |
| dc.date.none.fl_str_mv | 2025-11-25T13:06:13Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707401 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplementary_Figure_S6_from_Duvelisib_Eliminates_CLL_B_Cells_Impairs_CLL-Supporting_Cells_and_Overcomes_Ibrutinib_Resistance_in_a_Xenograft_Model/30707401 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Tumor Biology Therapeutic Research and Development Hematological Cancers Leukemias Small Molecule Agents Kinase inhibitors Tumor Microenvironment Immune cells and the microenvironment |
| dc.title.none.fl_str_mv | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Effects of treatment with duvelisib and ibrutinib on the numbers of T cells in in mice receiving samples from the same patients in Figure 6.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_baa747cf3011109a9bd8a6b0e3344ada |
| identifier_str_mv | 10.1158/1078-0432.30707401 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707401 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen (15314296)Jacqueline C. Barrientos (15314299)Gerardo Ferrer (15314302)Morgan King-Richards (15314305)Yu-Ju Chen (15314308)Priyadarshini Ravichandran (15314311)Michael Ibrahim (15314314)Yasmine Kieso (15314317)Sheila Waters (15314320)Jeffery L. Kutok (15314323)Marisa Peluso (15314326)Sujata Sharma (15314329)David T. Weaver (15314332)Jonathan A. Pachter (15027774)Kanti R. Rai (15314335)Nicholas Chiorazzi (15314338)CancerTumor BiologyTherapeutic Research and DevelopmentHematological CancersLeukemiasSmall Molecule AgentsKinase inhibitorsTumor MicroenvironmentImmune cells and the microenvironment<p>Effects of treatment with duvelisib and ibrutinib on the numbers of T cells in in mice receiving samples from the same patients in Figure 6.</p>2025-11-25T13:06:13ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30707401https://figshare.com/articles/figure/Supplementary_Figure_S6_from_Duvelisib_Eliminates_CLL_B_Cells_Impairs_CLL-Supporting_Cells_and_Overcomes_Ibrutinib_Resistance_in_a_Xenograft_Model/30707401CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307074012025-11-25T13:06:13Z |
| spellingShingle | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model Shih-Shih Chen (15314296) Cancer Tumor Biology Therapeutic Research and Development Hematological Cancers Leukemias Small Molecule Agents Kinase inhibitors Tumor Microenvironment Immune cells and the microenvironment |
| status_str | publishedVersion |
| title | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model |
| title_full | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model |
| title_fullStr | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model |
| title_full_unstemmed | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model |
| title_short | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model |
| title_sort | Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model |
| topic | Cancer Tumor Biology Therapeutic Research and Development Hematological Cancers Leukemias Small Molecule Agents Kinase inhibitors Tumor Microenvironment Immune cells and the microenvironment |